Innoviva (INVA) Net Margin (2011 - 2026)
Innoviva (INVA) posted Net Margin of 190.41% for Q1 2026, up 112.09% on a QoQ basis from 1575.3% in Q4 2025, and up 24298.0% year-over-year from N/an in Q1 2025.
Innoviva (INVA) Net Margin (2011 - 2026) Analysis & Trends
Innoviva's Net Margin history runs 16 years deep, the most recent figure standing at 190.41% for Q1 2026.
- Quarterly Net Margin rose 24298.0% year-over-year to 190.41% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 68.58% (up 8910.0% YoY) and the FY2025 annual result came in at 79.47%, up 7294.0% from the prior year.
- Net Margin was 190.41% for Q1 2026 at Innoviva, up from 1575.3% in the prior quarter.
- Across five years, Net Margin topped out at 1887.66% in Q1 2023 and bottomed at 11507.0% in Q4 2023.
- A 5-year average of 668.34% and a median of 36.07% in 2025 frame the typical range for Net Margin.
- Annual changes were most pronounced in 2023 — Net Margin plunged 999387 bps — and 2024, when it surged 1024878 bps.
- Innoviva's Net Margin stood at 1513.13% in 2022, then sank by 660 bps to 11507.0% in 2023, then jumped by 89 bps to 1258.22% in 2024, then retreated by 25 bps to 1575.3% in 2025, then jumped by 112 bps to 190.41% in 2026.
- Business Quant data shows INVA's Net Margin at 190.41% in Q1 2026, 1575.3% in Q4 2025, and 36.07% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 15.02% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 34.53% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 20.17% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 30.33% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Innoviva | 1.57 Bn | 969.11 Mn | 75.83 Mn | 190.41% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 190.41% |
| Dec 31, 2025 | -1,575.30% |
| Sep 30, 2025 | 36.07% |
| Jun 30, 2025 | 63.51% |
| Mar 31, 2025 | -52.56% |
| Dec 31, 2024 | -1,258.22% |
| Sep 30, 2024 | 1.16% |
| Jun 30, 2024 | -34.72% |
| Mar 31, 2024 | 1,464.47% |
| Dec 31, 2023 | -11,507.00% |
| Sep 30, 2023 | 52.62% |
| Jun 30, 2023 | 45.28% |
| Mar 31, 2023 | 1,887.66% |
| Dec 31, 2022 | -1,513.13% |
| Sep 30, 2022 | 106.29% |
| Jun 30, 2022 | 22.86% |
| Mar 31, 2022 | 708.90% |
| Dec 31, 2021 | -4,537.82% |
| Sep 30, 2021 | 89.91% |
| Jun 30, 2021 | 3,248.65% |